Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center.
adverse events
blepharospasm
botulinum toxin
long-term
outcome
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
07 02 2022
07 02 2022
Historique:
received:
30
12
2021
revised:
27
01
2022
accepted:
02
02
2022
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Aim of this study was to investigate the long-term results of botulinum toxin A (BoNT-A) injections for the treatment of benign essential blepharospasm (BEB) and to report our experience with (ultra-)long-term treatment with onabotulinumtoxin-A. We conducted a retrospective cross-sectional analysis at a university hospital. Patients with BEB and BoNT-A treatment were assigned to the Total Blepharospasm Group, patients with ≥21 onabotulinumtoxin-A injections to the Ona Long-Term Group. The Total Blepharospasm Group (
Identifiants
pubmed: 35202148
pii: toxins14020120
doi: 10.3390/toxins14020120
pmc: PMC8875585
pii:
doi:
Substances chimiques
Neuromuscular Agents
0
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Ophthalmol. 1985 Feb 15;99(2):176-9
pubmed: 3970122
Eye (Lond). 2010 Apr;24(4):600-7
pubmed: 19648904
Arq Neuropsiquiatr. 2005 Jun;63(2A):221-4
pubmed: 16100966
Am J Ophthalmol. 2013 Jul;156(1):173-177.e2
pubmed: 23541393
J Neural Transm (Vienna). 2015 Mar;122(3):427-31
pubmed: 25059456
J Neurol. 2000 Oct;247(10):787-92
pubmed: 11127535
JAMA. 1982 Dec 17;248(23):3160-4
pubmed: 7143695
Neurotox Res. 2009 Apr;15(3):224-31
pubmed: 19384595
J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):633-9
pubmed: 2213039
Mov Disord. 2002 Jan;17(1):7-12
pubmed: 11835433
Eur J Neurol. 2006 May;13(5):433-44
pubmed: 16722965
Clin Exp Ophthalmol. 2014 Apr;42(3):254-61
pubmed: 23844601
Medicine (Baltimore). 2021 Jun 25;100(25):e26481
pubmed: 34160460
Ger J Ophthalmol. 1995 Nov;4(6):363-7
pubmed: 8751102
Klin Monbl Augenheilkd. 1986 Oct;189(4):283-5
pubmed: 3807220
Arch Ophthalmol. 1985 Mar;103(3):347-50
pubmed: 3977705
Surv Ophthalmol. 2007 Jan-Feb;52(1):13-31
pubmed: 17212988
Neurology. 2016 May 10;86(19):1818-26
pubmed: 27164716
J Neural Transm (Vienna). 2011 Jun;118(6):925-43
pubmed: 21221669
Eur Neurol. 2015;73(5-6):337-41
pubmed: 25997849
Int Ophthalmol Clin. 2005 Summer;45(3):49-75
pubmed: 15970766
Eur J Ophthalmol. 2003 May;13(4):331-6
pubmed: 12872788
Toxins (Basel). 2013 Feb 04;5(2):249-66
pubmed: 23381141
Arq Neuropsiquiatr. 2012 Sep;70(9):662-6
pubmed: 22990720
Curr Opin Ophthalmol. 2018 Sep;29(5):440-444
pubmed: 29916840